Gene :: Gene therapy for blindness clears hurdle in mice
University of Florida researchers have used an experimental therapy in mice to shut down a gene that plays a crucial role in a leading cause of inherited blindness.
University of Florida researchers have used an experimental therapy in mice to shut down a gene that plays a crucial role in a leading cause of inherited blindness.
A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine.
Patients in Liverpool are to trial a new therapy for pancreatic cancer — a disease which sees most sufferers die within a year of diagnosis.
A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine
Women who develop preeclampsia during pregnancy are more likely to develop certain dangerous autoantibodies than women with normal pregnancies, and these autoantibodies are still present two years after childbirth in about 20 percent of women who had the disorder, scientists from the University of Pittsburgh report in the March issue of Hypertension, the journal of the American Heart Association.
Does God or some other type of transcendent entity answer prayer? The answer, according to a new Arizona State University study published in the March journal Research on Social Work Practice, is ?yes.?
Ultrasound-based tests allowing women undergoing in-vitro fertilization (IVF) to count their chickens before they’ve hatched may provide alternatives to the hormone-based tests used today.
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks.
The US Food and Drug Administration (FDA) approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
AIDS Healthcare Foundation (AHF), the US? largest HIV/AIDS healthcare and prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today excoriated US drug giant, Abbott Laboratories for its heartless decision to blacklist the country of Thailand by withdrawing its new drugs? applications from that country?s government review process?a move which in essence deprives Thailand and its citizens of access to any new Abbott medications.